Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4446863 | 0.83 | GAA (0.38) | GAAMEN1KMT2A | |
| SCHEMBL893078 | 0.83 | GAA (0.38) | GAAMEN1KMT2A | |
| SCHEMBL13009446 | 0.81 | GAA (0.39) | GAAMEN1KMT2A | |
| SCHEMBL2814073 | 0.80 | GAA (0.36) | GAAMEN1KMT2A | |
| SCHEMBL2810597 | 0.79 | GAA (0.36) | GAAMEN1KMT2ALMNA | |
| SCHEMBL13009238 | 0.78 | GAA (0.37) | GAAMEN1KMT2A | |
| SCHEMBL12910935 | 0.78 | GAA (0.37) | GAAMEN1KMT2AKDM4E | |
| SCHEMBL1001848 | 0.77 | MAPT (0.36) | GAAMEN1KMT2A | |
| SCHEMBL2814613 | 0.77 | MAPT (0.36) | GAAMEN1KMT2A | |
| SCHEMBL1828803 | 0.77 | MAPT (0.36) | GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11161813-B2 | Sterically hindered amines | BASF SE (DE) | 2021-11-02 | — | — | US | disclosed |
| US-20200123107-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2020-04-23 | — | — | US | disclosed |
| US-20180319746-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2018-11-08 | — | — | US | disclosed |
| US-10040762-B2 | Sterically hindered amines | BASF SE (DE) | 2018-08-07 | — | — | US | disclosed |
| EP-2545035-B1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2017-08-09 | — | — | EP | disclosed |
| EP-2440557-B1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2017-04-05 | — | — | EP | disclosed |
| US-9045480-B2 | Sterically hindered amine light stabilizers | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2010-09-30 | — | — | US | disclosed |
| EP-2035381-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | Ciba Holding Inc. (CH) | 2009-03-18 | — | — | EP | disclosed |
| US-7361755-B2 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-04-22 | — | — | US | disclosed |
| US-7361755-B2 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-04-22 | — | — | US | disclosed |
| US-7361755-B2 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-04-22 | — | — | US | disclosed |
| WO-2008003602-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003602-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| US-20050085636-A1 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORP. | 2005-04-21 | — | — | US | disclosed |
| EP-1456173-A1 | TRANSITION-METAL-CATALYZED PROCESS FOR THE CONVERSION OF ALKENES TO STERICALLY HINDERED SUBSTITUTED N-ALKOXYAMINES | Ciba SC Holding AG (CH) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003053931-A1 | TRANSITION-METAL-CATALYZED PROCESS FOR THE CONVERSION OF ALKENES TO STERICALLY HINDERED SUBSTITUTED N-ALKOXYAMINES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085636-A1 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | PNMT, NNMT, TET2 | GAA 3146/4885MEN1 607/4885KMT2A 167/4885 |
| US-11161813-B2 | Sterically hindered amines | H1-0, F12, H1-2 | GAA 3191/4885MEN1 586/4885KMT2A 273/4885 |
| US-20180319746-A1 | STERICALLY HINDERED AMINES | H1-0, F12, H1-2 | GAA 3191/4885MEN1 586/4885KMT2A 273/4885 |
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | PPOX, CBR1, CBR3 | GAA 1862/4885MEN1 4841/4885KMT2A 2110/4885 |
| US-20200123107-A1 | STERICALLY HINDERED AMINES | H1-0, F12, H1-2 | GAA 3191/4885MEN1 586/4885KMT2A 273/4885 |
| US-10040762-B2 | Sterically hindered amines | H1-0, F12, H1-2 | GAA 3191/4885MEN1 586/4885KMT2A 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.